EcoDrugPlus

60s Ribosomal Protein L7

Ensembl ID : ENSSARG00000007647
Gene Symbol: LOC101555984
2 External references
169 Possible Orthologues:

60s Ribosomal Protein L7-Like

Ensembl ID : ENSSARG00000007457
Gene Symbol: LOC101558795
2 External references
169 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSSARG00000012194
Gene Symbol: ADAMTS5
1 External references
200 Possible Orthologues:

Akt Serine/threonine Kinase 2

Ensembl ID : ENSSARG00000000417
Gene Symbol: AKT2
1 External references
253 Possible Orthologues:

Akt Serine/threonine Kinase 3

Ensembl ID : ENSSARG00000013947
Gene Symbol: AKT3
1 External references
201 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSSARG00000002602
Gene Symbol: ABCB1
1 External references
161 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSSARG00000006683
Gene Symbol: ABCC9
1 External references
229 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSSARG00000004972
Gene Symbol: ATP1A1
3 External references
322 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSSARG00000006199
Gene Symbol: ATP1B2
1 External references
274 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSSARG00000006060
Gene Symbol: ATP1B3
3 External references
299 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSSARG00000004427
Gene Symbol: ATR
1 External references
206 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSSARG00000006923
Gene Symbol: BRAF
3 External references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).